Given the increased GLP-1 RA use, particularly off-label, vigilance for pancreatitis symptoms is crucial, and a detailed medication history should be a routine part of evaluating acute abdominal pain
Accessed 04 Sept 2023
After initiating Semaglutide treatment, the patient reported a significant decrease in abdominal pain and an increase in bowel movement frequency, alongside a 7% reduction in body weight over six months
2f), and led to an ischaemia-evoked fall of perfusion volume similar to that seen with ischaemia/reperfusion alone ( p = 1.7 10 5 compared to RPc+Ex9 group, Fig
Das SR, Everett BM, Birtcher KK, et al
Your blood sugar levels may increase, and any weight lost while on the medication might be regained over time